Skip to main content

October 2008, Vol 1, No 8

Editorial
Writing Research Articles on Benefit Design and Policy
William E. Fassett, BSPharm, MBA, PhD, Charles R. Phillips, PharmD, PhD
Read More
Regulatory
Cutting Through the Politics: Presidential Candidates? Healthcare Platforms and Impact on Health Benefits
Peyton Howell, MHA
Stakeholder Perspective
Health Reform and the Next President
by Joseph R. Antos, PhD
Read More
Business
Medication Therapy Management Goes Hi-Tech: Implementing Automated Software Improves Pharmacy Efficiency
Adrienne Giordano, PharmD, Carrie Holden, PharmD, Cathrine Misquitta, PharmD, BCPS
Stakeholder Perspective
Automated MTM Programs
by Scott R. Taylor, RPh, MBA
Read More
Industry Trends
Presidential Candidates Strong Supporters of Greater Access to Generics and Biosimilars
Dalia Buffery, MA, ABD
Read More
Business
Cost-Effectiveness of Second-Generation Antihistamines and Montelukast in Relieving Allergic Rhinitis Nasal Symptoms
Michael J. Goodman, PhD, Mehul Jhaveri, PharmD, Kim Saverno, PhD, Kellie Meyer, PharmD, Brian Nightengale, PhD
Stakeholder Perspective
Relieving Nasal Symptoms: Uncommon Excellence in a Common Clinical Condition
by Michael F. Murphy, MD, PhD
Read More
FDA Approvals
New Reporting System for Potential Safety Concerns of Drugs on the Market
Mark Senak, JD
Read More
Clinical
Evaluation and Management of Diabetes Mellitus
Loida Nguyen, PharmD, James V. Felicetta, MD, Quang T. Nguyen, DO, FACE, FTOS
Stakeholder Perspective
Evidence-Based Diabetes Management
by Thomas McCarter, MD, FACP
Read More

Results 1 - 7 of 7